Neuroendoscopy Devices Market Demand Analysis: 2023–2033

The global neuroendoscopy devices market is poised for solid growth over the next decade, according to a recent market analysis. The market, valued at $214.5 million in 2023, is expected to reach $345 million by 2033, reflecting a compound annual growth rate (CAGR) of 4.9%. This growth trajectory follows the steady growth from 2018 to 2022, when the market expanded at a compound annual growth rate of 4.0% to reach $204.4 million in 2022.

One of the major factors driving the market expansion is the growing demand for neuroendoscopy devices, fueled by significant technological advancements. The development of fiber optics and imaging has revolutionized neuroendoscopy, making endoscopic procedures more common in neurological treatment. These advancements have led to increased precision and safety of surgery, thereby increasing the global adoption of neuroendoscopy devices.

Request a sample report: https://www.futuremarketinsights.com/reports/sample/rep-gb-14926

Neuroendoscopy, a minimally invasive surgical procedure, allows neurosurgeons to access and treat areas of the brain that are otherwise difficult to reach. The less invasive nature of the procedure results in a shorter recovery time and a lower risk of complications, making it an increasingly preferred option for both patients and healthcare providers.

The market growth is further supported by ongoing research and development efforts aimed at improving the functionality and effectiveness of neuroendoscopy devices. Innovations such as high-resolution imaging systems, flexible endoscopes, and advanced navigation tools are expected to propel the market forward, offering better outcomes for patients undergoing neurological procedures.

As the global healthcare industry continues to evolve, demand for advanced medical technologies such as neuroendoscopy devices is expected to increase. The projected growth of the neuroendoscopy market underscores the importance of continued investment in medical technology to meet the growing needs of neurological patients worldwide.

Key conclusions:

The UK neuroendoscopy market is expected to expand at a compound annual growth rate (CAGR) of 4.2% until 2033.
In 2022, the United States expanded the neuroendoscopy device business with a share of 33.7%.
The neuroendoscopy devices market has grown significantly, reaching a value of USD 204.4 million in 2022.
The neuroendoscopy devices market grew at a compound annual growth rate (CAGR) of 4.0% during 2018–2022.
The neuroendoscopy devices market in China is expected to grow at a compound annual growth rate (CAGR) of 7.4% through 2033.
The Indian neuroendoscopy devices industry is expected to grow at a compound annual growth rate (CAGR) of 6.1% until 2033.
The neuroendoscopy device industry in Japan has seen significant growth, reaching a market share of 5.0% in 2022.
The neuroendoscopy devices market in Australia is expected to expand at a compound annual growth rate (CAGR) of 5.4% through 2033.
The neuroendoscopy device business in Germany grew to reach 8.7% share in 2022
In 2022, based on device type, rigid neuroendoscopy dominated the market with a share of 70.1%.
In 2022, the hospital segment was the market leader, with a share of 52.5% in terms of end use.

Request a custom report: https://www.futuremarketinsights.com/customization-available/rep-gb-14926

Key Player Strategies and Recent Events:

As neuroendoscopy techniques are less invasive, the market for such devices is growing rapidly. Moreover, increasing efforts by major competitors in the market to introduce state-of-the-art neuroendoscopy to various neurological surgeries are supporting the revenue growth throughout the forecast period.

According to ClearMind Biomedical, the Axonpen system, a state-of-the-art neuroendoscopy method, received approval from the U.S. Food and Drug Administration in January 2021.
- Neuroendoscopy allows for controlled aspiration of tissue and fluids during surgery, as well as illumination and imaging of intracranial tissues and fluids.
- With this regulatory approval, the company has expanded its research and development capabilities and broadened its product offering.
Adeor Medical AG and ClearPoint Neuro, Inc., a global provider of a therapeutic platform offering brain-based advice and services, announced a strategic alliance in August 2021.
- This partnership included the distribution of neurosurgical instruments and supplies by ClearPoint Neuro, Inc. in the United States.
- Thanks to this strategic collaboration, the organization has expanded its customer base and increased sales.

Foncepi Comercial Exportadora Ltda
B. Braun
Karl Storz
Olympus Corporation
Stryker
Medtronic
Ackermann Instruments GmbH
Adeor Medical AG
Clarus Medical LLC
Machida Endoscope
Tonglu WANHE Medical Instrument
Hawk
Schindler Endoscopy Technologie GmbH
Others

Key segments:

By type of operation:

Intraventricular
Transcranial
Transnasal

By device type:

Rigid neuroendoscopy
Flexible neuroendoscopy

By application:

Hospitals
Medical Research Centers

By region:

North America
Latin America
Europe
Asia and Pacific
Middle East and Africa

Request your order now: https://www.futuremarketinsights.com/checkout/14926

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award winner and member of the Greater New York Chamber of Commerce) offers in-depth insights into the factors driving market demand. FMI is a leading global provider of market intelligence, advisory services, consulting and events for the packaging, food and beverage, consumer technology, healthcare, industrial and chemical markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional and local expertise on various industry disciplines and trends in over 110 countries.

Contact us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Apartment 401, Newark, Delaware – 19713, USA
Phone: +1-845-579-5705
For commercial inquiries: [email protected]
Website: https://www.futuremarketinsights.com
LinkedIn | Twitter| Blogs | YouTube